Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Nec
ClinicalTrials.gov study NCT05668949. IPD Sharing: Not stated. Countries: 0. Publications: 0.
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
ClinicalTrials.gov study NCT06835179. IPD Sharing: NO. Countries: 0. Publications: 0.
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
ClinicalTrials.gov study NCT06212388. IPD Sharing: NO. Countries: 0. Publications: 0.
The Effect of Previous Pregnancies in Patients With Gynecological Neoplasms Treated With PD-1/PD-L1 Inhibitors
ClinicalTrials.gov study NCT06945601. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer
ClinicalTrials.gov study NCT06818773. IPD Sharing: Not stated. Countries: 0. Publications: 0.
PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.
ClinicalTrials.gov study NCT05207735. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)
ClinicalTrials.gov study NCT06424717. IPD Sharing: YES. Countries: 0. Publications: 0.
MFOLFOXIRI Plus PD-1 Inhibitor Vs MFOLFOX6 As Neoadjuvant Therapy for Locally Advanced Colon Cancer
ClinicalTrials.gov study NCT06890624. IPD Sharing: NO. Countries: 0. Publications: 0.
NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus NALIRIFOX as Conversion Therapy of Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT06669078. IPD Sharing: NO. Countries: 0. Publications: 0.
CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients
ClinicalTrials.gov study NCT04990557. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT06465446. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer
ClinicalTrials.gov study NCT07394192. IPD Sharing: NO. Countries: 0. Publications: 0.
Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC
ClinicalTrials.gov study NCT05534113. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers
ClinicalTrials.gov study NCT00722306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma
ClinicalTrials.gov study NCT05461235. IPD Sharing: NO. Countries: 0. Publications: 0.
Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure
ClinicalTrials.gov study NCT06336954. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures
ClinicalTrials.gov study NCT06713798. IPD Sharing: NO. Countries: 1. Publications: 0.
Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males
ClinicalTrials.gov study NCT06901726. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03816657. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Neurofeedback Training for PD
ClinicalTrials.gov study NCT05987865. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.